Table 2. Pre-hyperpnea (baseline) pulmonary function.

Treatment Period
	Pre-treatment (n = 20)	Montelukast (n = 10)	Fish Oil (n = 10)	Combination Treatment (n = 20)
FVC (L)	4.51±0.22	4.30±0.18	4.64±0.43	4.61±0.31
% predicted	105.0±3.3%	100.9±4.4%	106.6±5.7%	105.7±3.9%
FEV1 (L)	3.67±0.19	3.34±0.19	3.81±0.31	3.69±0.24
% predicted	100.8±4.2%	96.1±6.3%	102.5±5.6%	102.3±5.0%
FEF25–75% (L/min)	3.67±0.27	3.00±0.26	3.82±0.38	3.71±0.29
% predicted	90.6±6.3%	80.7±6.4%	100.3±8.8%	91.7±6.8%

Values reported are mean ± SEM.